ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study

Published on 27 Nov 2024 on Zacks · via Yahoo Finance

Alector stock falls as the phase II INVOKE-2 study evaluating AL002 in slowing disease progression...

Read the rest of the article

Start tracking your investments with Statfolio

Alector stock falls as the phase II INVOKE-2 study evaluating AL002 in slowing disease progressio...

Zacks · via Yahoo Finance 27 Nov 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.28%

Investing.com 27 Nov 2024

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining around 0.1%...

Benzinga 26 Nov 2024

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Alector (ALEC) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estim...

Zacks via Yahoo Finance 8 May 2024

The market expects Alector (ALEC) to deliver a year-over-year increase in earnings on lower reven...

Zacks via Yahoo Finance 25 Apr 2024

Alector, Inc. (NASDAQ:ALEC) Q4 2023 Earnings Call Transcript February 27, 2024 Alector, Inc. beat...

Insider Monkey via Yahoo Finance 28 Feb 2024

Washington Post 27 Feb 2024

Alector (ALEC) shares ended the last trading session 6% higher at $6.40. The jump came on an impr...

Zacks via Yahoo Finance 8 Feb 2024

Key Insights Significantly high institutional ownership implies Alector's stock price is sensitiv...

Simply Wall St. via Yahoo Finance 31 Jan 2024